Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Ionis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Ionis Pharmaceuticals Inc
Rating: 1.408736125
Author: Trendlyne DVM scores

Momentum Trap

about

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

75.36 1.32 (1.78%)

214.66% Gain from 52W Low

3.2M

XNAS Volume

XNAS 09 Mar, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Ionis Pharma Inc is on 17 Mar 2026 for the purpose of Stifel 2026 Virtual CNS Forum See details

Low Financial Strength

27.8 / 100

Expensive Valuation

7.3 / 100

Technically Neutral

49.8 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 25%

22 analysts

Ionis Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

214.66% Gain from 52W Low

SWOT Analysis

Ionis Pharma Inc Live Price Chart